INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 21,600 Value ($000) $400 Avg Close Range
Q2 2023
Shares 12,747 Value ($000) $141 Avg Close Range
Q1 2023
Shares 12,747 Value ($000) $171 Avg Close Range
Q4 2022
Shares 12,747 Value ($000) $158 Avg Close Range
Q3 2022
Shares 12,747 Value ($000) $178 Avg Close Range
Q2 2022
Shares 16,476 Value ($000) $228 Avg Close Range
Q1 2022
Shares 16,476 Value ($000) $268 Avg Close Range
Q4 2021
Shares 11,215 Value ($000) $183 Avg Close Range
Q3 2021
Shares 11,215 Value ($000) $167 Avg Close Range
Q2 2021
Shares 11,215 Value ($000) $224 Avg Close Range
Q1 2021
Shares 11,215 Value ($000) $259 Avg Close Range
Q4 2020
Shares 11,215 Value ($000) $277 Avg Close Range
Q3 2020
Shares 11,215 Value ($000) $465 Avg Close Range
Q2 2020
Shares 11,215 Value ($000) $537 Avg Close Range
Q1 2020
Shares 11,215 Value ($000) $706 Avg Close Range
Q4 2019
Shares 11,215 Value ($000) $1,390 Avg Close Range
Q3 2019
Shares 11,215 Value ($000) $744 Avg Close Range
Q2 2019
Shares 11,215 Value ($000) $892 Avg Close Range
Q1 2019
Shares 9,678 Value ($000) $1,083 Avg Close Range
Q4 2018
Shares 9,678 Value ($000) $975 Avg Close Range
Q3 2018
Shares 9,225 Value ($000) $1,166 Avg Close Range
Q2 2018
Shares 10,153 Value ($000) $852 Avg Close Range